Creative Medical Technology Holdings, Inc. State and Local Income Tax Expense (Benefit), Continuing Operations
Creative Medical Technology Holdings, Inc. (CELZ) reported State and Local Income Tax Expense (Benefit), Continuing Operations of $342.37 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-03-20
- Creative Medical Technology Holdings, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2025 was $342.37K, a 9.76% increase from fiscal 2024.
- Creative Medical Technology Holdings, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2024 was $311.93K, a 3.71% increase from fiscal 2023.
- Creative Medical Technology Holdings, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2023 was $300.78K, a 48.36% decline from fiscal 2022.
- Creative Medical Technology Holdings, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2022 was $582.46K, a 543.89% increase from fiscal 2021.
| Period end | State and Local Income Tax Expense (Benefit), Continuing Operations 12 month | State and Local Income Tax Expense (Benefit), Continuing Operations 12 month as first filed |
|---|---|---|
| 2025-12-31 | $342.37K 10-K · filed 2026-03-20 | |
| 2024-12-31 | $311.93K 10-K · filed 2026-03-20 | |
| 2023-12-31 | $300.78K 10-K · filed 2025-03-14 | |
| 2022-12-31 | $582.46K 10-K · filed 2024-03-22 | |
| 2021-12-31 | $90.46K 10-K · filed 2023-03-31 | $9.46K 10-K · filed 2022-03-30 |
| 2020-12-31 | $69.67K 10-K · filed 2022-03-30 | |
| 2019-12-31 | $75.79K 10-K · filed 2021-03-17 | -$75.79K 10-K · filed 2020-04-06 |
| 2018-12-31 | -$234.67K 10-K · filed 2020-04-06 | |
| 2017-12-31 | -$212.73K 10-K · filed 2019-04-01 | |
| 2016-12-31 | -$61.29K 10-K · filed 2018-03-29 | |
| 2015-12-31 | $0.00 10-K · filed 2017-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |